Boostimmune secures Japanese patent for TCTP antibody tech
July 14, 2026 | 11:46
Boostimmune secured a Japanese patent covering antibody technology that inhibits translationally controlled tumour protein released from dead tumour cells, suppressing the accumulation of immune-suppressive cells.
Mobile Version